• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

IT/Security Leaders Can No Longer Rely Solely on Perimeter Security

by Syed Hamza Sohail 12/16/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
IT/Security Leaders Can No Longer Rely Solely on Perimeter Security

What You Should Know:

– Imprivata, the digital identity company for life- and mission-critical industries, today released new research that reveals over 91% of security leaders agree they can no longer rely solely on perimeter security to combat and respond to cyber threats, with 99% having experienced a cyberattack in the past year.

– The report outlines how healthcare, finance, manufacturing, pharmaceutical, and biotech organizations are approaching cyber and privacy risks. Cross-industry, 58% cite an increased frequency of attacks –to the tune of 21%, on average. Moreover, the rise of remote work has largely contributed to the growth of attack surfaces. Subsequently, 67% are focusing on security beyond the firewall as one of their top three investment priorities this year. Commonly referred to as “identity-based” or “identity” security, this approach is focused on ensuring users are only able to access the data and resources they need –a cornerstone of Zero Trust.

The Growing Concerns Regarding Cyber Threats

Imprivata is the digital identity company for mission- and life-critical industries, redefining how organizations solve complex workflow, security, and compliance challenges with solutions that protect critical data and applications without workflow disruption. The study was conducted by Vanson Bourne on behalf of Imprivata and includes insights from more than 750 IT security leaders spanning healthcare, finance, manufacturing, pharmaceutical, and biotech organizations across the US, UK, Australia, and Germany.

Though the concept of Zero Trust isn’t new, the adoption of technologies to facilitate a Zero Trust Architecture (ZTA) varies. “What we learned from this data is that businesses are under significant strain to mitigate attacks and manage the eye-watering costs when they occur. Yet less than half have the recommended digital identity technologies in place to protect themselves,” said Wes Wright, chief technology officer at Imprivata. “Despite the widespread familiarity with Zero Trust principles, fewer than half of those surveyed have adopted the foundational technologies needed to achieve them.” 

Solutions like identity governance, privileged access management (PAM), vendor privileged access management (VPAM), multifactor authentication (MFA), and single sign-on(SSO) enable greater security and compliance without negatively impacting end-user workflows. The low adoption rates seen in the study may be a result of apprehension; that doing so will hinder user productivity, particularly given the sizable number (57%) who cite user-centric security as a top priority.

Other key findings include:

– Third-party data breaches are a leading attack vector: More organizations are leveraging vendors, partners, and contractors as essential business resources. Interestingly, 40% of those surveyed report falling victim to a third-party data breach in the last 12 months yet just 42% have deployed VPAM to manage and control third-party access.

– Rising cyber insurance costs and insufficient coverage:40% of respondents cite increased cyber insurance costs as the most common negative impact following a cyberattack, adding that their premiums have risen by an average of 35% in the past year alone. Further, 48% say their policy doesn’t cover real-life scenarios.

– Patient lives at risk: For healthcare organizations, the cost of a cyberattack often goes beyond monetary to affect patient care. In fact, three in ten (31%) of those surveyed report that procedures and tests have been delayed that resulted in poor outcomes.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Biotech, foundational, Imprivata, Partners, Patient Care, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |